| ASSET | QUARTER | % RETURN |
|---|---|---|
QXO (QXO) | Q2 2012 | 13,440,500% |
Expedia (EXPE) | Q2 2012 | 44.86% |
Edwards Lifesciences (EW) | Q2 2012 | 41.93% |
Logitech International (LOGI) | Q2 2012 | 37.86% |
Vertex Pharmaceuticals (VRTX) | Q2 2012 | 37.26% |
Madrigal Pharmaceuticals (MDGL) | Q2 2012 | 26.33% |
Coca-Cola Femsa SAB de CV ADR (KOF) | Q2 2012 | 25.61% |
DexCom (DXCM) | Q2 2012 | 25.22% |
Toll Brothers (TOL) | Q2 2012 | 24.45% |
Flutter Entertainment (FLUT) | Q2 2012 | 24.41% |
Sherwin-Williams (SHW) | Q2 2012 | 23.58% |
HCA Healthcare (HCA) | Q2 2012 | 23.2% |
PulteGroup (PHM) | Q2 2012 | 22.43% |
Align Technology (ALGN) | Q2 2012 | 22.12% |
DR Horton (DHI) | Q2 2012 | 22% |
Agnico Eagle Mines (AEM) | Q2 2012 | 21.84% |
Royal Gold (RGLD) | Q2 2012 | 20.9% |
Axon Enterprise (AXON) | Q2 2012 | 20.46% |
Telkom Indonesia (Persero) Tbk PT ADR Rep 100 B (TLK) | Q2 2012 | 20.06% |
West Pharmaceutical Services (WST) | Q2 2012 | 19.57% |
Texas Pacific Land (TPL) | Q2 2012 | 19.44% |
CoStar (CSGP) | Q2 2012 | 18.13% |
Hershey (HSY) | Q2 2012 | 18.11% |
Brookfield (BN) | Q2 2012 | 18.06% |
Incyte (INCY) | Q2 2012 | 17.68% |
Large-cap stocks are treated as having a market cap of $10B+.